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The incidence of Candida infections (Candidosis) has increased remarkably in the last years, being attributed to the rise in the elderly population, the
increasing number of immunocompromised patients, and the widespread use of indwelling medical devices. Candida albicans remains as the most prevalent
species of these infections, but a clear rise in the proportion of non-Candida albicans Candida (NCAC) species has been noted. These species have an
inherent level of resistance to certain antifungal agents higher than C. albicans though their virulence factors are much less understood. A major virulence
factor is the ability to adhere and to form biofilms in medical devices and host tissues, because of a higher tolerance to antifungal therapy. Consequently,
there is an urgent need to develop new strategies to fight these infections. Natural compounds are attracting increased interest in this field, among which
honey. AIM: To evaluate honey as a novel strategy to fight C. tropicalis infections.
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Honey (Manuka and Urze) was tested alone against Candida (C. albicans; C. tropicalis; C. parapsilosis; C. glabrata) planktonic cultures and in combination with antifungal
agents (fluconazole, chlorhexidine, nystatin) against single and mixed (with Pseudomonas aeruginosa) biofilms.
 Effect of honey on planktonic cells (MIC)  Effect of honey on single and dual-species biofilms (CFUs)
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 Effect of honey and honey + antifungal on single biofilms cells (CFUs and Live/Dead)
EFFECT OF HONEY IN PLANKTONIC CANDIDA SPP. CULTURE EFFECT OF HONEY + ANTIFUNGAL AGENTS IN C. tropicalis BIOFILMS EFFECT OF HONEY ACTIVITY IN MIXED- SPECIES BIOFILMS
Table 1. MIC values of honey in Candida spp. planktonic cultures
EFFECT OF HONEY IN C. tropicalis BIOFILM CULTURE
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Figure 1. Therapeutic effect of honey against C. tropicalis biofilms.
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Figure 2. Therapeutic combined effect of honey and antifungal agents
(Fluconazole (a); Chorhexidine (b); Nystantin(c)) against C. tropicalis biofilms.
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Figure 3. Therapeutic effect of honey against C. tropicalis and Pseudomonas aeruginosa mixed-
biofilms cultures. (*P<0.05 compared with
control)
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 A first screening of the treatment with four planktonic Candida species culture indicated higher efficiency of honey against C. tropicalis.
 Honey is capable of 2-log reductions on C. tropicalis biofilms after 24h of treatment
 The combination of honey with nystatin and chlorhexidine reduces the antifungal dosage typically required in clinical settings by 50%, with a total biofilm reduction of 3-log
with nystatin and 5-logs with chlorhexidine.
 In mixed biofilms of C. tropicalis and P. aeruginosa, honey at 50% or above reduces yeast and bacterial biofilm by 2-log and 4-log, respectively.
Altogether, our results highlight the great potential of honey as an alternative or complimentary strategy for the control of Candida infections.
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